Status:
COMPLETED
Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Diabetes Mellitus
Diabetic Retinopathy
Eligibility:
All Genders
Phase:
NA
Brief Summary
Recurrent vitreous hemorrhage after vitrectomy for complications of diabetic retinopathy is a common occurrence. The hemorrhage may appear within the first few weeks after surgery or months later. Thi...
Detailed Description
The study consisted of two parts. Part one was prospective clinical observational study; part two was case control study. From January 2005 to May 2005, consecutive patients undergoing primary pars p...
Eligibility Criteria
Inclusion
- patients undergoing primary pars plana vitrectomy for complications of proliferative diabetic retinopathy were recruited for the prospective study
Exclusion
- (1) anticoagulant therapy had been used prior to surgery or during post-operative follow-up period; (2) positive medical history of blood diseases associated with abnormal blood coagulation.
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00155454
Start Date
September 1 2004
End Date
December 1 2012
Last Update
December 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan